fbpx

pharmaceutical law

Tag Archive

More Philips CPAP Machine Recalls

More Philips CPAP Machine Recalls

| Pharmaceutical Litigation
After it received several reports of serious and fatal injuries, the Food and Drug Administration (FDA) ordered an immediate recall of Philips Respironics V60 and V60 Plus Ventilators. Hospitals often use these ventilators for patients who cannot breathe on their own, have chronic breathing problems, or suffer from severe sleep apnea. An unexplained power fluctuation…Read the article
Pharmaceuticals and Deceptive Advertising: When Can You Sue?

Pharmaceuticals and Deceptive Advertising: When Can You Sue?

| Pharmaceutical Litigation
Pharmaceuticals and Deceptive Advertising: When Can You Sue? Pharmaceuticals are a multi-billion dollar industry in the United States. However, with that kind of money at stake, there are companies who try to cut corners by engaging in deceptive advertising practices. If you have suffered harm or injury because of pharmaceuticals as a result of deceptive…Read the article
Did Zantac Cause My Cancer? How to Know

Did Zantac Cause My Cancer? How to Know

| Pharmaceutical Litigation
Zantac is one of the brand names of ranitidine, a generic medicine. It’s one of the many medications used to treat the symptoms of acid reflux, also known as gastroesophageal reflux disease (GERD), or heartburn. However, some patients develop cancer symptoms while or after using the drug. Zantac can be cancer causing, and the Federal…Read the article
What to Do If Your CPAP or BiPAP Machine Has Been Recalled

What to Do If Your CPAP or BiPAP Machine Has Been Recalled

| Pharmaceutical Litigation
Chronic respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and asthma affect millions of people worldwide. To date, there are around 235 million people living with asthma all over the world. Those who have been exposed to certain environmental factors such as exposure to the 9/11 World Trade Center attacks have been shown to…Read the article
FDA Finds Cancer-Causing Agent in Metformin

FDA Finds Cancer-Causing Agent in Metformin

| Pharmaceutical Litigation
The sudden recall of a popular diabetes drug because of NDMA contamination (cancer-causing agent) creates a cloud over the Food and Drug Administration’s entire review process. Time-Cap Labs Inc.’s generic drug is used to treat Type 2 diabetes. Its lower cost makes it a popular alternative to brand-name drugs. When the most recent test results…Read the article
How Safe Are Dietary Supplements?

How Safe Are Dietary Supplements?

| Pharmaceutical Litigation
Will dietary supplement keep me safe from coronavirus? Physical health often wards off viral infections. But tread cautiously. In the United States, dietary supplements exist in a legal grey area. So, they are not always safe. Dietary health is essential for overall physical health. Supplements do not replace a healthy diet, but in many cases,…Read the article
Bladder Medication Can Cause Blindness

Bladder Medication Can Cause Blindness

| Pharmaceutical Litigation
Orphan drug affects eyesight Having been widely prescribed for decades, the Elmiron bladder medication has recently been found to be toxic to the retina (damage). An article published by the American Academy of Ophthalmology in 2018 described six patients experiencing pigmentary maculopathy after chronic exposure to Elmiron (pentosan polysulfate sodium) for interstitial cystitis. The following…Read the article
Government Recalls Diabetes Drug

Government Recalls Diabetes Drug

| Pharmaceutical Litigation
After government inspectors found traces of a cancer-causing chemical in Metformin, the Food and Drug Administration ordered a recall of one of the most commonly-prescribed diabetes drugs in America. FDA officials discovered a dangerous chemical, N-Nitrosodimethylamine, in five different Metformin versions. About 34 million Americans have Type 2 Diabetes, and many of them take some…Read the article
Prescription Weight Loss Drug Pulled Off The Market

Prescription Weight Loss Drug Pulled Off The Market

| Pharmaceutical Litigation
In 2012, the FDA approved the first new prescription weight loss drug in thirteen years: lorcaserin, marketed as Belviq. Available to patients in the US since June 2013 in a twice-daily dose, it was soon (2016) followed by once-a-day Belviq XR. Expectations crushed Nevertheless, this herald of hope for almost one third of Americans rated…Read the article
Headaches Ahead for Zantac Labs

Headaches Ahead for Zantac Labs

| Pharmaceutical Litigation
Heartburn Heaven As recently as August 2019, the ranitidine market was tipped to top a gut-gripping US$ 485.4 million by 2026. Introduced in 1981, this popular antacid – better known as Zantac – was the world’s top-selling prescription drug just six years later. In fact, sweetening the world’s sour stomachs proved a bottomless well of…Read the article